Brave Asset Management’s Amgen AMGN Stock Holding History

Brave Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Sell	2,940 -526	-15%	-$180K	0.23%	42
2026 Q1	$1.22M	Buy	3,466 +125	+4%	+$44.6K	0.29%	39
2025 Q4	$1.09M	Sell	3,341 -184	-5%	-$58.4K	0.26%	40
2025 Q3	$995K	Buy	3,525 +600	+21%	+$174K	0.24%	45
2025 Q2	$817K	Hold	2,925	–	–	0.22%	49
2025 Q1	$911K	Sell	2,925 -30	-1%	-$8.86K	0.28%	45
2024 Q4	$770K	Hold	2,955	–	–	0.24%	48
2024 Q3	$952K	Sell	2,955 -240	-8%	-$78.5K	0.23%	45
2024 Q2	$998K	Sell	3,195 -733	-19%	-$215K	0.25%	39
2024 Q1	$1.12M	Sell	3,928 -134	-3%	-$39.2K	0.29%	37
2023 Q4	$1.17M	Sell	4,062 -25	-0.6%	-$6.81K	0.33%	31
2023 Q3	$1.1M	Sell	4,087 -161	-4%	-$40.2K	0.34%	34
2023 Q2	$943K	Buy	4,248 +59	+1%	+$13.7K	0.28%	40
2023 Q1	$1.01M	Buy	4,189 +1,198	+40%	+$294K	0.32%	36
2022 Q4	$786K	Sell	2,991 -2,527	-46%	-$677K	0.27%	46
2022 Q3	$1.24M	Sell	5,518 -46	-0.8%	-$11.2K	0.63%	24
2022 Q2	$1.35M	Sell	5,564 -9	-0.2%	-$2.21K	0.61%	27
2022 Q1	$1.35M	Sell	5,573 -38	-0.7%	-$8.73K	0.46%	33
2021 Q4	$1.26M	Sell	5,611 -20	-0.4%	-$4.22K	0.35%	34
2021 Q3	$1.2M	Sell	5,631 -235	-4%	-$54.1K	0.35%	34
2021 Q2	$1.43M	Sell	5,866 -414	-7%	-$102K	0.42%	33
2021 Q1	$1.56M	Buy	6,280 +1,299	+26%	+$310K	0.53%	30
2020 Q4	$1.15M	Sell	4,981 -9,282	-65%	-$2.14M	0.43%	38
2020 Q3	$3.63M	Buy	14,263 +212	+2%	+$52.5K	1.72%	17
2020 Q2	$3.31M	Buy	14,051 +868	+7%	+$198K	1.73%	16
2020 Q1	$2.67M	Buy	13,183 +215	+2%	+$47K	1.67%	15
2019 Q4	$3.13M	Buy	12,968 +103	+0.8%	+$22.7K	1.62%	18
2019 Q3	$2.49M	Sell	12,865 -377	-3%	-$72.4K	1.43%	19
2019 Q2	$2.44M	Buy	13,242 +679	+5%	+$122K	1.37%	21
2019 Q1	$2.39M	Buy	12,563 +646	+5%	+$123K	1.33%	21
2018 Q4	$2.32M	Sell	11,917 -194	-2%	-$37.8K	1.56%	22
2018 Q3	$2.51M	Buy	12,111 +22	+0.2%	+$4.34K	1.29%	25
2018 Q2	$2.23M	Buy	12,089 +2,520	+26%	+$446K	1.3%	26
2018 Q1	$1.63M	Buy	9,569 +35	+0.4%	+$6.42K	0.98%	36
2017 Q4	$1.66M	Sell	9,534 -235	-2%	-$41.6K	0.86%	38
2017 Q3	$1.82M	Sell	9,769 -174	-2%	-$30.8K	0.96%	34
2017 Q2	$1.71M	Buy	9,943 +2,744	+38%	+$446K	0.91%	31
2017 Q1	$1.18M	Buy	7,199 +2,624	+57%	+$436K	0.69%	40
2016 Q4	$669K	Buy	4,575 +675	+17%	+$102K	0.43%	69
2016 Q3	$651K	Buy	3,900 +2,249	+136%	+$380K	0.42%	68
2016 Q2	$251K	Buy	1,651 +1,351	+450%	+$210K	0.17%	114
2016 Q1	$45K	Hold	300	–	–	0.03%	222
2015 Q4	$49K	Hold	300	–	–	0.03%	221
2015 Q3	$41K	Hold	300	–	–	0.03%	226
2015 Q2	$46K	Hold	300	–	–	0.03%	233
2015 Q1	$48K	Sell	300 -30	-9%	-$4.72K	0.03%	227
2014 Q4	$53K	Hold	330	–	–	0.04%	219
2014 Q3	$46K	Hold	330	–	–	0.03%	228
2014 Q2	$39K	Hold	330	–	–	0.03%	245
2014 Q1	$41K	Hold	330	–	–	0.03%	232
2013 Q4	$38K	Buy	+330	New	+$37.5K	0.03%	234

Other funds holding AMGN

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Brave Asset Management's AMGN Position: Q2 2026 in Review

Brave Asset Management reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $180K and leaving 2,940 shares worth $1.06M. The position accounts for 0.23% of the portfolio, ranked #42.

Brave Asset Management first reported a position in AMGN in Q4 2013 and has held it in 51 quarters since. The position peaked at $3.63M in Q3 2020. 1,540 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Brave Asset Management held 2,940 shares of Amgen worth $1.06M as of Q2 2026.
Brave Asset Management sold 526 Amgen shares in Q2 2026, an estimated $180K.
Amgen made up 0.23% of Brave Asset Management's portfolio in Q2 2026, its #42 holding.
Brave Asset Management first reported a position in Amgen in Q4 2013 and has held it in 51 quarters since.
Brave Asset Management's Amgen position peaked at $3.63M in Q3 2020.
1,540 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Brave Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.